Scientific Program - Retina

Print
Please see below the COPHy AA ScientificProgram. Please click on the appropriate section to view the relevant program. Please note that the program is subject to change. To view the program timetable / overview, please click here

Retina
     
Glaucoma Anterior Segment Neuro-ophthalmology
FRIDAY, FEBRUARY 22, 2019
HALL A
08:30-10:00
OPENING SESSION | Big Controversies in Ophthalmology in 2019
Chairs:
Neil Bressler, USA 
08:30-09:00
Debate I: Proliferative diabetic retinopathy: Five-year outcomes confirm anti-VEGF without PRP is an acceptable initial treatment
08:30-08:40
08:40-08:50
08:50-09:00
Yes: Susan Bressler, USA
No
Discussion
 
09:00-09:30
Debate II: Neuro-protection in glaucoma: A viable pursuit
09:00-09:10
09:10-09:20
09:20-09:30
Yes: Christopher Leung, Hong Kong
No
Discussion
 
09:30-10:00
Debate III: Atrophine should be used in children to prevent myopia
09:30-09:40
09:40-09:50
09:50-10:00
Yes: Tien Yin Wong, Singapore
No, not in all cases
Discussion
 
10:00-10:30 Visit to Exhibits - Coffee and Refreshment Break
 
10:30-12:00
RETINA I | Choroidal Neovascular Age-related Macular Degeneration
Chairs:
Xiaoxin Li, China; Adrian Koh, Singapore 
10:30-11:00
Debate I: Treat and extend regimens are superior to PRN regimens
10:30-10:40
10:40-10:50
10:50-11:00
Yes: Gemmy Cheung, Singapore
No: Susan Bressler, USA
Discussion
 
11:00-11:30
Debate II: Large submacular hemorrhages typically should be managed initially with surgery, not anti-VEGF injections
11:00-11:10
11:10-11:20
11:20-11:30
Yes: Yaiji Sakamoto, Japan
No: Paisan Ruamviboonsuk, Thailand
Discussion
 
11:30-12:00
 
Debate III: New agents or delivery devices represents a clinically relevant advance in managing neovascular AMD
11:30-11:40
11:40-11:50
11:50-12:00
Yes: Jun Kong, China
No: Sherman Valero, Philippines
Discussion
 
12:00-12:15 Visit to Exhibits & Technical Break
 
12:15-13:15 INDUSTRY-SPONSORED LUNCHEON SYMPOSIUM (NOT FOR CME)
 
13:15-13:45 Visit to Exhibits - Dessert Break
 
13:45-15:15
RETINA II | Diabetic Macular Edema
Chairs: Xiaofeng Lin, China; Susan Bressler, USA 
13:45:14:15 Debate I: Consider alternative treatment regimens for patients with suboptimal vision responses after first 3 intravitreal anti-VEGF injections
13:45-13:55
13:55-14:05
14:05-14:15
Yes: Michaella Goldstein, Israel
No: Voraporn Chikitmongkol, Thailand
Discussion
 
14:15-14:45 Debate II: For persistent DME after 6 injections, add focal/grid laser
14:15-14:25
14:25-14:35
14:35-14:45
Yes: Jun Kong, China
No: Timothy Lai, Hong Kong
Discussion
 
14:45-15:15 Debate III: Artificial intelligence is ready to be used widely for DR Screening
14:45-14:55
14:55-15:05
15:05-15:15
Yes
No: Daniel Ting, Singapore
Discussion
 
15:15-16:45 RETINA III| Retinal Detachment and Vitrectomy
Chairs: Joseph Moisseiev, Israel; Taiji Sakamoto, Japan 
15:15-15:45 Debate I: Non-clearing vitreous hemorrhage in PDR: Try a series of anti-VEGF injections before going to vitrectomy
15:15-15:25
15:25-15:35
15:35-15:45
Yes: Adrian Koh, Singapore
No: Taiji Sakamoto, Japan
Discussion
 
15:45-16:15 Debate II: Vitrectomy alone is superior to a scleral buckle for a total RD with small tear at 1 o'clock in a phakic 40-year old eye
15:45-15:55
15:55-16:05
16:05-16:15
Yes: Adiel Barak, Israel
No: Joseph Moisseiev, Israel
Discussion
 
16:15-16:45 Debate III: Attempt to treat focal vitreomacular traction with gas injection should be tried before considering vitrectomy
16:15-16:25
16:25-16:35
16:35-16:45
Yes: Shibo Tang, China
No: Adiel Barak, Israel
Discussion
END OF DAY FRIDAY HALL A

SATURDAY, FEBRUARY 23, 2019
HALL A
09:00-10:00
Vision Academy in Retina 2019
Chairs:
 
 
09:00-09:10 An introduction to Vision Academy
 
09:10-09:30
Debate I: A fellow eye to an eye with actively treated CMV would best be monitored by sophisticated home monitoring technology (PHP, Home OCT)
09:10-09:15
09:15-09:20
09:20-09:25
09:25-09:30
Yes
No
Presentation of viewpoint
Questions
 
09:30-09:50
Debate II: Futility of treatment: In some cases in which no improvement is anticipated treatment should be stopped
09:30-09:35
09:35-09:40
09:40-09:45
09:45-09:50
Yes
No
Presentation of viewpoint
Questions
 
09:50-10:00 Looking forward with the Vision Academy
 
10:00-10:30 Visit to Exhibits - Coffee and Refreshment Break
 
10:30-12:00
RETINA IV | Polypoidal Choroidal Vasculopathy
Chairs: Adrian Koh, Singapore; Won Ki Lee, South Korea 
10:30-11:00 Debate I: EVEREST 2 and PLANET results should be compared
10:30-10:40
10:40-10:50
10:50-11:00
Yes: Won Ki Lee, South Korea
No: Adrian Koh, Singapore
Discussion
 
11:00-11:30 Debate II: ICG Angiography is needed to manage most cases of PCV
11:00-11:10
11:10-11:20
11:20-11:30
Yes
No: Voroporn Chaikitmongkol, Thailand
Discussion
 
11:30-12:00 Debate III: OCT-Angiography is useful in management of PCV
11:30-11:40
11:40-11:50
11:50-12:00
Yes: Gemmy Cheung, Singapore
No: Timothy Lai, Hong Kong
Discussion
 
12:00-12:15 Visit to Exhibition & Lunch Box Pick Up
 
12:15-13:15 INDUSTRY-SPONSORED LUNCHEON SYMPOSIUM (NOT FOR CME)
 
13:15-13:45 Visit to Exhibits - Dessert Break
 
13:45-15:15
RETINA V | Pathologic Myopia
Chairs: Hua Yan, China; Joseph Moisseiev, Israel 
13:45:14:15 Debate I: Reduce children’s time indoors to reduce incidence of pathologic myopia
13:45-13:55
13:55-14:05
14:05-14:15
Yes
No
Discussion
 
14:15-14:45 Debate II: Macular hemorrhage without leakage on fluorescein or ICG angiography should be treated empirically with anti-VEGF therapy or PDT with verteporfin for possible choroidal neovascularization obscured by hemorrhage
14:15-14:25
14:25-14:35
14:35-14:45
Yes: Young Hee Yoon, South Korea
No: Shibo Tang, China
Discussion
 
14:45-15:15 Debate III: Myopic foveoschisis should be treated by vitrectomy
14:45-14:55
14:55-15:05
15:05-15:15
Yes: Joseph Moissieiv, Israel
No: Adiel Barak, Israel
Discussion
 
15:15-16:45
RETINA VI | Retinal Vein Occlusions
Chairs: Xiaoling Liang, China; Timothy Lai, Hong Kong 
15:15-15:45 Debate I: Intravitreal steroids are a viable choice as first line therapy
15:15-15:25
15:25-15:35
15:35-15:45
Yes: Barry Kuppermann, USA
No: Gemmy Cheung, Singapore
Discussion
 
15:45-16:15 Debate II: SCORE 2 results: Choose aflibercept over bevacizumab for macular edema secondary to central retinal vein occlusion
15:45-15:55
15:55-16:05
16:05-16:15
Yes: Susan Bressler, USA
No: Young Hee Yoon, South Korea
Discussion
 
16:15-16:45 Debate III: Unilateral retinal vein occlusions in older individuals typically warrant work-up for systemic disease
16:15-16:25
16:25-16:35
16:35-16:45
Yes: Paisan Ruamviboonsuk, Thailand
No
Discussion
 
17:00-18:30
Think Tank: Controversies Across Ophthalmology
Chairs: Xiaxin Li, China; Tin Aung, Singapore; Paisan Ruamviboonsuk, Thailand 
17:00-17:30 Debate I: Removal of cataract increases the risk of progression of macular degeneration
17:00-17:10
17:10-17:20
17:20-17:30
Yes: Barry Kuppermann, USA
No
Discussion
 
17:30-18:00 Debate II: Big data are the next big thing in ophthalmology
17:30-17:40
17:40-17:50
17:50-18:00
Yes: Daniel Ting, Singapore
No: Sherman Valero, Philippines
Discussion
 
18:00-18:30 Spirinolactone is effective as a treatment for CSR
18:00-18:10
18:10-18:20
18:20-18:30
Yes
No: Michaella Goldstein, Israel
Discussion
END OF DAY SATURDAY HALL A